ATE55617T1 - Expressionsvektoren. - Google Patents

Expressionsvektoren.

Info

Publication number
ATE55617T1
ATE55617T1 AT83305424T AT83305424T ATE55617T1 AT E55617 T1 ATE55617 T1 AT E55617T1 AT 83305424 T AT83305424 T AT 83305424T AT 83305424 T AT83305424 T AT 83305424T AT E55617 T1 ATE55617 T1 AT E55617T1
Authority
AT
Austria
Prior art keywords
rna
dna sequence
vector
copy number
expression
Prior art date
Application number
AT83305424T
Other languages
English (en)
Inventor
Nikos Panayotatos
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Application granted granted Critical
Publication of ATE55617T1 publication Critical patent/ATE55617T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT83305424T 1982-09-16 1983-09-15 Expressionsvektoren. ATE55617T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8226409 1982-09-16
EP83305424A EP0104061B1 (de) 1982-09-16 1983-09-15 Expressionsvektoren

Publications (1)

Publication Number Publication Date
ATE55617T1 true ATE55617T1 (de) 1990-09-15

Family

ID=10532945

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83305424T ATE55617T1 (de) 1982-09-16 1983-09-15 Expressionsvektoren.

Country Status (6)

Country Link
US (1) US4716112A (de)
EP (1) EP0104061B1 (de)
JP (1) JPS5991887A (de)
AT (1) ATE55617T1 (de)
CA (1) CA1209501A (de)
DE (1) DE3381813D1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4710473A (en) * 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
HU194307B (en) * 1983-09-16 1988-01-28 Richter Gedeon Vegyeszet Process for producing plasmidvectors of high copy number
GB8407498D0 (en) * 1984-03-22 1984-05-02 Biogen Nv High copy number expression vectors
IL71555A (en) * 1984-04-15 1992-06-21 State Of Israel Israel Inst Fo Bovine interferon
AU600885B2 (en) * 1984-05-25 1990-08-30 Zymogenetics Inc. Stable DNA constructs
US5973115A (en) * 1987-05-15 1999-10-26 Amgen Inc. Method for potentiating and inhibiting insulin-like growth factor activity
AU1955388A (en) * 1988-04-12 1989-11-03 Synergen, Inc. Method for potentiating and inhibiting insulin-like growth factor activity
US5256568A (en) * 1990-02-12 1993-10-26 Regeneron Phamaceuticals, Inc. Vectors and transformed most cells for recombinant protein production with reduced expression of selectable markers
FR2678947B1 (fr) * 1991-07-12 1993-11-05 Institut Recherche Agronomique Origine de replication plasmidique augmentant le nombre de copies du plasmide comprenant ladite origine.
JPH07163368A (ja) * 1993-12-15 1995-06-27 Hayashibara Biochem Lab Inc 組換えｄｎａとその組換えｄｎａを含む形質転換体
US5824497A (en) * 1995-02-10 1998-10-20 Mcmaster University High efficiency translation of mRNA molecules
CA2279673A1 (en) 1995-12-15 1997-06-16 Enzo Therapeutics, Inc. Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acids for therapeutic and diagnostic uses
US6268178B1 (en) 1999-05-25 2001-07-31 Phage Biotechnology Corp. Phage-dependent super-production of biologically active protein and peptides
EP1195436A1 (de) * 2000-10-04 2002-04-10 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Expressionsvektoren mit veränderter ColE1 Replikationsursprung zur Kontrolle der Plasmidkopienzahl

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2759053A1 (de) * 1977-12-30 1979-07-12 Uhlin Verfahren zum herstellen von genprodukten von plasmid-dns
FI793884A7 (fi) * 1978-12-26 1981-01-01 Cetus Corp Vakaita runsaasti jäljentyviä plasmideja.
US4332892A (en) * 1979-01-15 1982-06-01 President And Fellows Of Harvard College Protein synthesis
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
IE63126B1 (en) * 1980-06-06 1995-03-22 Biogen Inc Improved vectors and methods for making such vectors and for expressing cloned genes
JPS5756495A (en) * 1980-09-24 1982-04-05 Kyowa Hakko Kogyo Co Ltd Novel dna-introduction vector and recombinant dna
CA1198067A (en) * 1981-02-27 1985-12-17 David H. Gelfand Stable high copy number plasmids
IL66065A (en) * 1981-06-22 1989-06-30 Lilly Co Eli Recombinant dna cloning vectors and the e.coli transformants thereof
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
DE3279270D1 (en) * 1981-09-02 1989-01-12 Biogen Nv Amplified expression of dna sequences

Also Published As

Publication number Publication date
EP0104061A1 (de) 1984-03-28
DE3381813D1 (en) 1990-09-20
JPS5991887A (ja) 1984-05-26
CA1209501A (en) 1986-08-12
US4716112A (en) 1987-12-29
EP0104061B1 (de) 1990-08-16

Similar Documents

Publication Publication Date Title
ATE55617T1 (de) Expressionsvektoren.
BG60107B2 (bg) Метод за получаване на еукариотен полипептид
MD430C2 (ro) Procedeu de obţinere a interferonelor leucocitare umane
DK0776331T3 (da) Struktur af højere orden og binding af peptidnukleinsyrer
ES8306797A1 (es) Un metodo para producir un polipeptido.
DK0559884T4 (da) Rekombinante virusvektorer til ekspression i muskelceller
DE3471688D1 (en) Dna vectors and their use in recombinant dna technology
ATE348175T1 (de) Method eder intrazellularen bindung von zielgerichteten molekülen
IL59007A (en) Recombinant dna molecules coding for polypeptides displaying hepatitis b virus antigenicity,method of their production and compositions containing the same
FI811009A7 (fi) Parannettuja vektoreita, näiden vektoreiden valmistusmenetelmiä ja kloonattujen geenien ekspressiomeneekspressiomenetelmiä.
ATE295889T1 (de) Gentranskription und ionisierende strahlung: methoden und zusammensetzungen
ES8705521A1 (es) Un metodo de producir un polipetido similar a factor de necrosis de tumores (tnf) de mamiferos.
NO155145C (no) Stabile, vandige opploesninger av vinylkopolymerisater som oppviser anioniske grupper og flerverdige kationiske forbindelser eller kationtensider og anvendelse av opploesningene som haardhetsstabiliseringsmidler.
DK251890D0 (da) Polypeptid og dets anvendelse samt ekspressionssystem til dets eksprimering
ATE173023T1 (de) Dna-sequenzen kodierend für das polypeptid gelonin
DK346385A (da) Genetiske sekvenser, hermed kodede interferon-peptider af type i og organismer, der producerer disse
KR930701610A (ko) 미생물의 세포, 조직 또는 숙주 지향성을 변화시키는 방법, 이 방법으로 수득된 재조합 미생물, 및 의학 및 수의학분야에서 이들을 사용하는 방법
IE811049L (en) Cloned fmdv antigens
DK0612218T3 (da) Hidtil ukendte coleoptera-aktive isolater fra Bacillus thuringiensis samt gener, der koder for coleoptera-aktive toksiner
FR2710074B1 (fr) Gène GRB3-3, ses variants et leurs utilisations.
SE8101665L (sv) Polypeptidframstellning
DE3586473D1 (de) Den lambda pl-promotor enthaltende plasmide sowie technisch hergestellte restriktionsstelle zum einfachen ersatz einer ribosomalen bindungsstelle, die plasmide enthaltende wirte und entsprechende verfahren.
NO870948L (no) Vektor, samt fremgangsmŸte for frembringelse av en transformert cellelinje med hŸyt ekspresjonsnivŸ.
DE69112834D1 (de) Einführung der transkription regulierende nukleotidsequenz.
ES8307893A1 (es) "procedimiento para la mejora de la amplificacion y de la expresion de vectores hibridos".

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties